Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 1

Status

Recruiting 6Active not recruiting 5Completed 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 2Breast 2Thoracic 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Smoking Cessation 1Pancreatic Neoplasms 1Motor Activity 1Lung Neoplasms 1Inflammation 1

Interventions

Specimen Handling 218Magnetic Resonance Spectroscopy 194pembrolizumab 185Carboplatin 160Biopsy 129Cisplatin 128Nivolumab 119Paclitaxel 107Cyclophosphamide 104Radiotherapy 99Gemcitabine 96Dexamethasone 86durvalumab 83atezolizumab 70Rituximab 66Radiation 64Lenalidomide 64Doxorubicin 63Pemetrexed 61Bevacizumab 58Etoposide 56Docetaxel 56olaparib 50Ipilimumab 49Fluorouracil 48Taxes 47Prednisone 47Oxaliplatin 46Vincristine 45Cytarabine 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Diet Therapy × 90 days × Clear all
NCT01802346 2026-06-05

Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

University of Southern California

Phase NA Active not recruiting
130 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06090916 2026-05-26

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
100 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04267796 2026-04-16

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

M.D. Anderson Cancer Center

Phase NA Active not recruiting
40 enrolled 9 charts
Breast

Breast Neoplasms

NCT04985565 2026-04-09

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
12 enrolled
Genitourinary

Prostatic Neoplasms

NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡